Details
Zusammenfassung: <jats:p> Acute lymphoblastic leukemia (ALL) is a clonal disease that evolves through the accrual of genetic rearrangements and/or mutations within the dominant clone. The <jats:italic>TEL-AML1</jats:italic> ( <jats:italic>ETV6-RUNX1</jats:italic> ) fusion in precursor-B (pre-B) ALL is the most common genetic rearrangement in childhood cancer; however, the cellular origin and the molecular pathogenesis of <jats:italic>TEL-AML1</jats:italic> -induced leukemia have not been identified. To study the origin of <jats:italic>TEL-AML1</jats:italic> -induced ALL, we generated transgenic zebrafish expressing <jats:italic>TEL-AML1</jats:italic> either ubiquitously or in lymphoid progenitors. <jats:italic>TEL-AML1</jats:italic> expression in all lineages, but not lymphoid-restricted expression, led to progenitor cell expansion that evolved into oligoclonal B-lineage ALL in 3% of the transgenic zebrafish. This leukemia was transplantable to conditioned wild-type recipients. We demonstrate that <jats:italic>TEL-AML1</jats:italic> induces a B cell differentiation arrest, and that leukemia development is associated with loss of <jats:italic>TEL</jats:italic> expression and elevated <jats:italic>Bcl2</jats:italic> / <jats:italic>Bax</jats:italic> ratio. The <jats:italic>TEL-AML1</jats:italic> transgenic zebrafish models human pre-B ALL, identifies the molecular pathways associated with leukemia development, and serves as the foundation for subsequent genetic screens to identify modifiers and leukemia therapeutic targets. </jats:p>
Umfang: 15166-15171
ISSN: 1091-6490
0027-8424
DOI: 10.1073/pnas.0603349103